The NF-κB pathway contributes to cancer cell development/progression and drug resistance in pancreatic cancer by inhibiting cancer cell apoptosis and inducing expression of inflammatory cytokines (Fujioka et al., 2003; Prabhu et al., 2014; Yu and Kim, 2014). Here, NFKB1 is linked to familial pancreatic carcinoma.